HIV
From the Journals
Ibalizumab shows promise against MDR HIV-1
Ibalizumab can not only help decrease viral loads in patients with multidrug-resistant HIV type 1, but it also can help increase CD4 counts.
Conference Coverage
U.S. HIV clinical care fails the hardest hit
Conference Coverage
Dolutegravir plus 3TC matches three drugs for HIV control
Conference Coverage
On-demand and daily PrEP look similar for HIV prevention
Prospective study of more than 1,100 French MSM showed on-demand PrEP performed as well as daily PrEP for preventing HIV infection.
Conference Coverage
Rising U.S. PrEP use linked with dropping HIV infections
Conference Coverage
‘Undetectable’ HIV means ‘untransmissible’ confirmed in larger sex study
From the Journals
Genetic composition of HCV changes with HIV coinfection
Conference Coverage
People with HIV develop more frailty despite treatment
AMSTERDAM – Middle-aged and elderly people with HIV developed more frailty than did similar uninfected people, and frailty predicted worse...
Video
Incident heart failure linked to HIV infection
AMSTERDAM – Medical records from a large U.S. health system suggest that incident heart failure independently links to HIV infection.
Video
Novel HIV vaccine induces durable immune responses
AMSTERDAM – Follow-up of HIV-vaccine recipients 1 year after their final dose in a phase I/IIa trial showed continued safety and anti-HIV...
Feature
World off track for meeting 2020 HIV prevention, mortality goals